48 | | - | SECTION 1. NEW LAW A new section of law to be codified |
---|
49 | | - | in the Oklahoma Statutes as Section 6060.2a of Title 36, unless |
---|
50 | | - | there is created a duplication in numbering, reads as follows: |
---|
51 | | - | A. The State shall direct the creation of a discount progr am |
---|
52 | | - | that will allow participants t o purchase insulin at a discounted, |
---|
53 | | - | post-rebate rate. |
---|
54 | | - | B. As used in this section , unless the context otherwise |
---|
55 | | - | requires: |
---|
56 | | - | 1. "Participant" means a resident of Oklahoma who: |
---|
57 | | - | a. uses insulin to treat diabetes, |
---|
58 | | - | b. does not receive health coverage un der the program, |
---|
59 | | - | and |
---|
| 58 | + | SECTION 1. AMENDATORY 36 O.S. 2021, Section 6060.2, as |
---|
| 59 | + | amended by Section 1, Chapter 199 , O.S.L. 2022 (36 O.S. Supp. 2022, |
---|
| 60 | + | Section 6060.2), is amended to read as follows : |
---|
| 61 | + | Section 6060.2 A. 1. Every health benefit plan issued or |
---|
| 62 | + | renewed on or after November 1, 1996, s hall, subject to the terms of |
---|
| 63 | + | the policy contract or agreement, i nclude coverage for the following |
---|
| 64 | + | equipment, supplies and related services for th e treatment of Type |
---|
| 65 | + | I, Type II, and gestational diabetes, when medic ally necessary and |
---|
| 66 | + | when recommended or pre scribed by a physician or other l icensed |
---|
86 | | - | c. enrolls in the discount program; |
---|
87 | | - | 2. "Discount program" means a process developed by the program |
---|
88 | | - | that allows participants to purchase insulin at a discounted, post- |
---|
89 | | - | rebate rate; |
---|
90 | | - | 3. "Rebate" means a refund, discount, or other price concession |
---|
91 | | - | that is paid by a pharmaceutica l manufacturer to a pharmacy benefit |
---|
92 | | - | manager based on a prescription drug's utilization or effectiveness. |
---|
93 | | - | Rebate does not include an admi nistrative fee. |
---|
94 | | - | C. For the purpose of the insulin discount program only, the |
---|
95 | | - | program shall allow participants to purchase insul in at a |
---|
96 | | - | discounted, post-rebate rate. |
---|
97 | | - | D. The discount program described in this section shall: |
---|
98 | | - | 1. Provide a participant with a n electronic document that |
---|
99 | | - | identifies the participant as eligible for the discount; |
---|
100 | | - | 2. Provide a participant with information a bout pharmacies that |
---|
101 | | - | will honor the discount; |
---|
102 | | - | 3. Allow a participant to purchase insulin at a discounted, |
---|
103 | | - | post-rebate rate; and |
---|
104 | | - | 4. Provide a participant with instructions to pursue a |
---|
105 | | - | reimbursement of the purchase price from the participant 's health |
---|
106 | | - | insurer. |
---|
107 | | - | E. The discount program shall charge a p rice for the insulin |
---|
108 | | - | that allows the program to retain only enough of any rebate fo r the |
---|
| 94 | + | health care provider leg ally authorized to prescribe under the laws |
---|
| 95 | + | of this state: |
---|
| 96 | + | a. blood glucose monitors, |
---|
| 97 | + | b. blood glucose monitors to the legally blind, |
---|
| 98 | + | c. test strips for glucose monitors, |
---|
| 99 | + | d. visual reading and urine testing strips, |
---|
| 100 | + | e. insulin, |
---|
| 101 | + | f. injection aids, |
---|
| 102 | + | g. cartridges for the legally blind, |
---|
| 103 | + | h. syringes, |
---|
| 104 | + | i. insulin pumps and appurtenances theret o, |
---|
| 105 | + | j. insulin infusion devices, |
---|
| 106 | + | k. oral agents for controlling blood sugar, and |
---|
| 107 | + | l. podiatric appliances for pr evention of complications |
---|
| 108 | + | associated with diabetes. |
---|
| 109 | + | 2. The State Board of Health shall develop and annually update, |
---|
| 110 | + | by rule, a list of additional diabetes equipment, related supplies |
---|
| 111 | + | and health care provider servi ces that are medically necessary for |
---|
| 112 | + | the treatment of diabetes, for which c overage shall also be |
---|
| 113 | + | included, subject to the terms of the policy, contract, or |
---|
| 114 | + | agreement, if the equipment and supplies have been approved by the |
---|
| 115 | + | federal Food and Drug Administrat ion (FDA). Additional FDA-approved |
---|
| 116 | + | diabetes equipment and related supplies , and health care provider |
---|
| 117 | + | services shall be determined in consultation with a national |
---|
| 145 | + | diabetes association affi liated with this state, and at least three |
---|
| 146 | + | (3) medical directors of health benefit plans, to be selected by th e |
---|
| 147 | + | State Department of Health. |
---|
| 148 | + | 3. All policies specified in this section shall also include |
---|
| 149 | + | coverage for: |
---|
| 150 | + | a. podiatric health care provider servic es as are deemed |
---|
| 151 | + | medically necessary to prevent complications from |
---|
| 152 | + | diabetes, and |
---|
| 153 | + | b. diabetes self-management training. As used in this |
---|
| 154 | + | subparagraph, "diabetes self-management training" |
---|
| 155 | + | means instruction in an inpatient or outpatient |
---|
| 156 | + | setting which enables diabetic patients to understand |
---|
| 157 | + | the diabetic management process and daily management |
---|
| 158 | + | of diabetic therapy as a method of avoiding frequent |
---|
| 159 | + | hospitalizations and complications. Diabetes self- |
---|
| 160 | + | management training shall comply with standards |
---|
| 161 | + | developed by the State Board of Health in consultation |
---|
| 162 | + | with a national diabetes associa tion affiliated with |
---|
| 163 | + | this state and at lea st three medical directors of |
---|
| 164 | + | health benefit plans selected by th e State Department |
---|
| 165 | + | of Health. Coverage for diabetes self-management |
---|
| 166 | + | training, including medical nutrition therapy relating |
---|
| 167 | + | to diet, caloric intake, and diabetes management, but |
---|
| 168 | + | |
---|
| 169 | + | HB2351 HFLR Page 4 |
---|
| 170 | + | BOLD FACE denotes Committee Amen dments. 1 |
---|
| 171 | + | 2 |
---|
| 172 | + | 3 |
---|
| 173 | + | 4 |
---|
| 174 | + | 5 |
---|
| 175 | + | 6 |
---|
| 176 | + | 7 |
---|
| 177 | + | 8 |
---|
| 178 | + | 9 |
---|
| 179 | + | 10 |
---|
| 180 | + | 11 |
---|
| 181 | + | 12 |
---|
| 182 | + | 13 |
---|
| 183 | + | 14 |
---|
| 184 | + | 15 |
---|
| 185 | + | 16 |
---|
| 186 | + | 17 |
---|
| 187 | + | 18 |
---|
| 188 | + | 19 |
---|
| 189 | + | 20 |
---|
| 190 | + | 21 |
---|
| 191 | + | 22 |
---|
| 192 | + | 23 |
---|
| 193 | + | 24 |
---|
| 194 | + | |
---|
| 195 | + | excluding programs the only purpose of which a re |
---|
| 196 | + | weight reduction, shall be li mited to the following: |
---|
| 197 | + | (1) visits medically necessary upon the diagnosis of |
---|
| 198 | + | diabetes, |
---|
| 199 | + | (2) a physician diagnosis which represents a |
---|
| 200 | + | significant change in the symptoms or condition |
---|
| 201 | + | of the patient making medically necessary ch anges |
---|
| 202 | + | in the self-management of the patient, and |
---|
| 203 | + | (3) visits when reeducation or refresher training is |
---|
| 204 | + | medically necessary; |
---|
| 205 | + | provided, however, payment for the coverage required for d iabetes |
---|
| 206 | + | self-management training pursuant to the provisions of this section |
---|
| 207 | + | shall be required only upon cer tification by the health care |
---|
| 208 | + | provider providing the training that the patient ha s successfully |
---|
| 209 | + | completed diabetes self -management training. |
---|
| 210 | + | 4. Diabetes self-management training shall be sup ervised by a |
---|
| 211 | + | licensed physician o r other licensed health care pr ovider legally |
---|
| 212 | + | authorized to prescribe under the laws of this state. Diabetes |
---|
| 213 | + | self-management training may be provided by the physician or other |
---|
| 214 | + | appropriately registered, certified, or licens ed health care |
---|
| 215 | + | professional as part of an office visit for diabe tes diagnosis or |
---|
| 216 | + | treatment. Training provided by appropriately registered, |
---|
| 217 | + | certified, or licensed health care professionals may be provided in |
---|
| 218 | + | group settings where practicable. |
---|
| 219 | + | |
---|
| 220 | + | HB2351 HFLR Page 5 |
---|
| 221 | + | BOLD FACE denotes Committee Amen dments. 1 |
---|
| 222 | + | 2 |
---|
| 223 | + | 3 |
---|
| 224 | + | 4 |
---|
| 225 | + | 5 |
---|
| 226 | + | 6 |
---|
| 227 | + | 7 |
---|
| 228 | + | 8 |
---|
| 229 | + | 9 |
---|
| 230 | + | 10 |
---|
| 231 | + | 11 |
---|
| 232 | + | 12 |
---|
| 233 | + | 13 |
---|
| 234 | + | 14 |
---|
| 235 | + | 15 |
---|
| 236 | + | 16 |
---|
| 237 | + | 17 |
---|
| 238 | + | 18 |
---|
| 239 | + | 19 |
---|
| 240 | + | 20 |
---|
| 241 | + | 21 |
---|
| 242 | + | 22 |
---|
| 243 | + | 23 |
---|
| 244 | + | 24 |
---|
| 245 | + | |
---|
| 246 | + | 5. Coverage for diabetes self-management training and training |
---|
| 247 | + | related to medical nutrition therapy, when provided by a registered, |
---|
| 248 | + | certified, or licensed heal th care professional, shall also include |
---|
| 249 | + | home visits when medically necessary and shall include instruction |
---|
| 250 | + | in medical nutrition therapy only b y a licensed registered dietic ian |
---|
| 251 | + | or licensed certified nutritionist when authorized by the |
---|
| 252 | + | supervising physician of the patient when medically necessary. |
---|
| 253 | + | 6. Coverage may be subjec t to the same annual deductibles or |
---|
| 254 | + | coinsurance as may be deemed appropriat e and as are consistent with |
---|
| 255 | + | those established for other covered benefits within a given policy. |
---|
| 256 | + | 7. Any health benefit plan, as defined pursuant to Section |
---|
| 257 | + | 6060.4 of this title, that provides coverage for insulin pursuant to |
---|
| 258 | + | this section shall cap the t otal amount that a cov ered person is |
---|
| 259 | + | required to pay for insulin at an amount not to exceed Thirty |
---|
| 260 | + | Dollars ($30.00) per thirty-day supply or Ninety Dollars ($90.00) |
---|
| 261 | + | per ninety-day supply of insulin for each covered insulin |
---|
| 262 | + | prescription, regardless of the a mount or type of insul in needed to |
---|
| 263 | + | fill the prescription or prescriptions of the covered person. |
---|
| 264 | + | a. Nothing in this paragraph shall prev ent a health |
---|
| 265 | + | benefit plan from reducing the cos t-sharing of a |
---|
| 266 | + | covered person to an amount less than Thirty Dolla rs |
---|
| 267 | + | ($30.00) per thirty-day supply or Ninety Dollars |
---|
| 268 | + | ($90.00) per ninety-day supply. |
---|
| 269 | + | |
---|
| 270 | + | HB2351 HFLR Page 6 |
---|
| 271 | + | BOLD FACE denotes Committee Amen dments. 1 |
---|
| 272 | + | 2 |
---|
| 273 | + | 3 |
---|
| 274 | + | 4 |
---|
| 275 | + | 5 |
---|
| 276 | + | 6 |
---|
| 277 | + | 7 |
---|
| 278 | + | 8 |
---|
| 279 | + | 9 |
---|
| 280 | + | 10 |
---|
| 281 | + | 11 |
---|
| 282 | + | 12 |
---|
| 283 | + | 13 |
---|
| 284 | + | 14 |
---|
| 285 | + | 15 |
---|
| 286 | + | 16 |
---|
| 287 | + | 17 |
---|
| 288 | + | 18 |
---|
| 289 | + | 19 |
---|
| 290 | + | 20 |
---|
| 291 | + | 21 |
---|
| 292 | + | 22 |
---|
| 293 | + | 23 |
---|
| 294 | + | 24 |
---|
| 295 | + | |
---|
| 296 | + | b. The Insurance Commissioner shall ens ure all health |
---|
| 297 | + | benefit plans comply with the requirements of this |
---|
| 298 | + | paragraph. |
---|
| 299 | + | c. The Commissioner may promulgat e rules as necessary to |
---|
| 300 | + | implement and administer the requirements of this |
---|
| 301 | + | paragraph and to align with federal requirements. |
---|
| 302 | + | B. 1. Health benefit plans shall not reduce or eliminate |
---|
| 303 | + | coverage due to the requirement s of this section. |
---|
| 304 | + | 2. Enforcement of the provisions of this act shall be performed |
---|
| 305 | + | by the Insurance Department and the State Department of Health. |
---|
| 306 | + | C. As used in this section, "health benefit plan" means any |
---|
| 307 | + | plan or arrangement as d efined in subsection C of Section 6060.4 of |
---|
| 308 | + | this title. |
---|
| 309 | + | SECTION 2. NEW LAW A new section of law to be codified |
---|
| 310 | + | in the Oklahoma Statutes as Section 6060.2a of Title 36, unless |
---|
| 311 | + | there is created a duplication in numbering, reads as follows: |
---|
| 312 | + | A. The State shall direct the creation of a discount progr am |
---|
| 313 | + | that will allow participants t o purchase insulin at a discounted, |
---|
| 314 | + | post-rebate rate. |
---|
| 315 | + | B. As used in this section , unless the context otherwise |
---|
| 316 | + | requires: |
---|
| 317 | + | 1. "Participant" means a resident of Oklahoma who: |
---|
| 318 | + | a. uses insulin to treat diabetes, |
---|
| 319 | + | |
---|
| 320 | + | HB2351 HFLR Page 7 |
---|
| 321 | + | BOLD FACE denotes Committee Amen dments. 1 |
---|
| 322 | + | 2 |
---|
| 323 | + | 3 |
---|
| 324 | + | 4 |
---|
| 325 | + | 5 |
---|
| 326 | + | 6 |
---|
| 327 | + | 7 |
---|
| 328 | + | 8 |
---|
| 329 | + | 9 |
---|
| 330 | + | 10 |
---|
| 331 | + | 11 |
---|
| 332 | + | 12 |
---|
| 333 | + | 13 |
---|
| 334 | + | 14 |
---|
| 335 | + | 15 |
---|
| 336 | + | 16 |
---|
| 337 | + | 17 |
---|
| 338 | + | 18 |
---|
| 339 | + | 19 |
---|
| 340 | + | 20 |
---|
| 341 | + | 21 |
---|
| 342 | + | 22 |
---|
| 343 | + | 23 |
---|
| 344 | + | 24 |
---|
| 345 | + | |
---|
| 346 | + | b. does not receive health coverage un der the program, |
---|
| 347 | + | and |
---|
| 348 | + | c. enrolls in the discount program; |
---|
| 349 | + | 2. "Discount program" means a process developed by the program |
---|
| 350 | + | that allows participants to purchase insulin at a discounted, post - |
---|
| 351 | + | rebate rate; |
---|
| 352 | + | 3. "Rebate" means a refund, discount or other price concession |
---|
| 353 | + | that is paid by a pharmaceutica l manufacturer to a pharmacy benefit |
---|
| 354 | + | manager based on a prescription drug's utilization or effectiveness. |
---|
| 355 | + | "Rebate" does not include an administrative fee. |
---|
| 356 | + | C. For the purpose of the insulin discount program only, the |
---|
| 357 | + | program shall allow participants to purchase insul in at a |
---|
| 358 | + | discounted, post-rebate rate. |
---|
| 359 | + | D. The discount program described in this section shall: |
---|
| 360 | + | 1. Provide a participant with an electroni c document that |
---|
| 361 | + | identifies the participant as eligible for the discount; |
---|
| 362 | + | 2. Provide a participant with information a bout pharmacies that |
---|
| 363 | + | will honor the discount; |
---|
| 364 | + | 3. Allow a participant to purchase insulin at a discounted, |
---|
| 365 | + | post-rebate rate; and |
---|
| 366 | + | 4. Provide a participant with instructions to pursue a |
---|
| 367 | + | reimbursement of the purchase price from the participant 's health |
---|
| 368 | + | insurer. |
---|
| 369 | + | |
---|
| 370 | + | HB2351 HFLR Page 8 |
---|
| 371 | + | BOLD FACE denotes Committee Amen dments. 1 |
---|
| 372 | + | 2 |
---|
| 373 | + | 3 |
---|
| 374 | + | 4 |
---|
| 375 | + | 5 |
---|
| 376 | + | 6 |
---|
| 377 | + | 7 |
---|
| 378 | + | 8 |
---|
| 379 | + | 9 |
---|
| 380 | + | 10 |
---|
| 381 | + | 11 |
---|
| 382 | + | 12 |
---|
| 383 | + | 13 |
---|
| 384 | + | 14 |
---|
| 385 | + | 15 |
---|
| 386 | + | 16 |
---|
| 387 | + | 17 |
---|
| 388 | + | 18 |
---|
| 389 | + | 19 |
---|
| 390 | + | 20 |
---|
| 391 | + | 21 |
---|
| 392 | + | 22 |
---|
| 393 | + | 23 |
---|
| 394 | + | 24 |
---|
| 395 | + | |
---|
| 396 | + | E. The discount program shall charge a p rice for the insulin |
---|
| 397 | + | that allows the program to retain only enough of any rebate for the |
---|